(WHITEHOUSE STATION, N.J.) – Merck announced on Wednesday that the FDA has approved a new contraceptive, Nexaplanon, for the prevention of pregnancy in women for up to three years.
According to a company press release, Nexaplon is a long-acting, progestin-only single-rod hormonal contraceptive. It is the size of a matchstick and must be inserted under the skin of a woman’s upper arm with a minor surgical in-office procedure.
Merck claims that nexaplanon is effective with less than one pregnancy per every hundred women.
Copyright 2011 ABC New Radio